Is increased chronological age a contraindication to debulking surgery for elderly patients with advanced ovarian cancer?

被引:1
|
作者
Park, Soo Jin [1 ]
Mun, Jaehee [1 ]
Yim, Ga Won [2 ]
Lee, Maria [1 ]
Chung, Hyun Hoon [1 ]
Kim, Jae Weon [1 ]
Park, Noh Hyun [1 ]
Song, Yong Sang [1 ]
Kim, Hee Seung [1 ]
机构
[1] Seoul Natl Univ, Dept Obstet & Gynecol, Coll Med, 101 Daehak Ro, Seoul 03080, South Korea
[2] Dongguk Univ, Dept Obstet & Gynecol, Coll Med, Goyang, South Korea
关键词
Aged; ovarian neoplasm; postoperative complications; prognosis; surgical procedure; CYTOREDUCTIVE SURGERY; CHEMOTHERAPY; MORBIDITY; COMORBIDITY; TOXICITY; OUTCOMES; RISK;
D O I
10.1080/01443615.2022.2112021
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
We collected data of elderly patients aged 65 years and older who underwent debulking surgery for advanced ovarian cancer in order to explore the impact of old age on surgical outcomes and complications. A total of 120 patients were classified as follows: group 1, 65-69 years (n = 58); group 2, 70-74 years (n = 38); group 3, 75-79 years (n = 17); group 4, >= 80 years (n = 7). There were no differences in most of the characteristics, surgical extent and outcomes, and postoperative complications between the four groups, whereas polypharmacy was more common (6 vs. 5-16; p=.02) and operation time was shorter (median, 194 vs. 285-330 min; p=.02) in group 4. Factors related to frailty rather than age, polypharmacy, preoperative albumin level, estimated blood loss and transfusion increased the risk of postoperative complications. Thus, the impact of old age on surgical extent, outcomes and postoperative complications may be minimal in elderly patients with advanced ovarian cancer. Impact Statement What is already known on this subject? Optimal debulking surgery is a significant factor in improving the prognosis of ovarian cancer but it is not easy to perform such radical surgery on elderly patients in fear of increasing surgical morbidity and mortality. Some studies suggest that underlying comorbidities may be a stronger contributing factor to increasing such risk rather than old age although there is not enough evidence yet. What do the results of this study add? Through this study, we could see that increased age is not the determining cause of increased morbidity and mortality in elderly patients who undergo optimal debulking surgery in ovarian cancer. There are other aspects describing a patient's health status that can predict prognosis better rather than age. What are the implications of these findings for clinical practice and/or further research? Old age need not be a contraindication when performing optimal debulking surgery in elderly patients with advanced ovarian cancer.
引用
下载
收藏
页码:3254 / 3259
页数:6
相关论文
共 50 条
  • [21] Results of optimal debulking surgery with bowel resection in patients with advanced ovarian cancer
    Pawel Derlatka
    Jacek Sienko
    Laretta Grabowska-Derlatka
    Piotr Palczewski
    Anna Danska-Bidzinska
    Mariusz Bidzinski
    Krzysztof Czajkowski
    World Journal of Surgical Oncology, 14
  • [22] Results of interval debulking surgery compared with primary debulking surgery in advanced stage ovarian cancer
    Morice, P
    Dubernard, G
    Rey, A
    Atallah, D
    Pautier, P
    Pomel, C
    Lhommé, C
    Duvillard, P
    Castaigne, D
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2003, 197 (06) : 955 - 963
  • [23] DIAPHRAGMATIC SURGERY AS PART OF DEBULKING SURGERY FOR ADVANCED STAGE OVARIAN CANCER
    Vilcu, M.
    Balescu, I.
    Bacalbasa, N.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 640 - 640
  • [24] Surgery for metastatic spine tumors in the elderly. Advanced age is not a contraindication to surgery!
    Amelot, A.
    Balabaud, L.
    Choi, D.
    Fox, Z.
    Crockard, H. A.
    Albert, T.
    Arts, C. M.
    Buchowski, J. M.
    Bunger, C.
    Chung, C. K.
    Coppes, M. H.
    Depreitere, B.
    Fehlings, M. G.
    Harrop, J.
    Kawahara, N.
    Kim, E. S.
    Lee, C. S.
    Leung, Y.
    Liu, Z. J.
    Martin-Benlloch, J. A.
    Massicotte, E. M.
    Meyer, B.
    Oner, F. C.
    Peul, W.
    Quraishi, N.
    Tokuhashi, Y.
    Tomita, K.
    Ulbricht, C.
    Verlaan, J. J.
    Wang, M.
    Mazel, C.
    SPINE JOURNAL, 2017, 17 (06): : 759 - 767
  • [25] Should neoadjuvant chemotherapy be preferred to an alternative treatment for advanced ovarian cancer: Comparison of neoadjuvant chemotherapy followed by interval debulking surgery and primary debulking surgery in patients with advanced ovarian cancer
    Liu, J.
    GYNECOLOGIC ONCOLOGY, 2015, 137 : 176 - 176
  • [26] Primary debulking surgery versus neoadjuvant chemotherapy in elderly patients with epithelial ovarian cancer
    Xu, Z.
    Justiniano, C. F.
    Fleming, F. J.
    Boscoe, F. P.
    Schymura, M. J.
    Rubinsak, L. A.
    Morrow, G.
    Minasian, L.
    Temkin, S. M.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 78 - 78
  • [27] PRIMARY DEBULKING SURGERY (PDS) VERSUS NEOADJUVANT CHEMOTHERAPY FOLLOWED BY INTERVAL DEBULKING SURGERY (IDS) FOR PATIENTS WITH ADVANCED OVARIAN CANCER
    Obeidat, R.
    Saidi, S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [28] INTERVENTION DEBULKING SURGERY IN ADVANCED EPITHELIAL OVARIAN-CANCER
    REDMAN, CWE
    WARWICK, J
    LUESLEY, DM
    VARMA, R
    LAWTON, FG
    BLACKLEDGE, GRP
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1994, 101 (02): : 142 - 146
  • [29] Experience with PlasmaJet™ in debulking surgery in 87 patients with advanced-stage ovarian cancer
    Volcke, Alexander
    Van Nieuwenhuysen, Els
    Han, Sileny
    Salihi, Rawand
    Van Gorp, Toon
    Vergote, Ignace
    JOURNAL OF SURGICAL ONCOLOGY, 2021, 123 (04) : 1109 - 1114
  • [30] The role of primary debulking in advanced ovarian cancer patients
    Vlad, Catalin
    Kubelac, Paul
    Alexandru, Irimie
    Achimas-Cadariu, Patriciu
    JOURNAL OF BUON, 2016, 21 (05): : 1320 - 1320